March 7, 2013
/PRNewswire/ -- A study presented today at the National Business Group on Health's (NBGH) Business Health Agenda 2013 conference in
, showed that, on average, employers that use multiple cost management programs had a 50 percent lower specialty drug trend than employers that did not use any specialty management programs.
The study, conducted by Express Scripts (NASDAQ: ESRX), is one of the first to examine the impact of multiple utilization management programs on the cost of specialty medications — a cost that is expected to account for
out of every
spent on prescription medications by 2014.
"Specialty drug costs and use have escalated without sufficient oversight to manage waste or misuse of these expensive medications. Add in the impact of bad health decisions and you get both poor financial and clinical outcomes," said
, MD, senior vice president, Clinical, Research & New Solutions, Express Scripts. "This data clearly demonstrates that multiple progressive management solutions mitigate the rising cost of specialty therapies by identifying and seizing cost-saving opportunities, as well as enabling better decisions that can lead to improved health outcomes."
Many key factors contribute to the rising costs of specialty medications for complex diseases such as cancer, hepatitis C and multiple sclerosis, including price inflation, increasing utilization and new drug introductions. In some cases, these medications can cost upwards of
per person per year.
Express Scripts researchers analyzed the specialty drug spending of 60 employer clients who are members of NBGH, representing more than 5 million Americans with pharmacy benefits. The employers were categorized into one of three groups based on the type of cost management programs adopted:
- Unmanaged — employers whose health plan members could obtain their specialty medications from any pharmacy and did not use any specialty utilization management programs
- Somewhat managed — employers whose health plan members used a specialty pharmacy exclusively and one specialty utilization management program
- Tightly managed — consisting of employers whose health plan members used a specialty pharmacy exclusively combined with multiple specialty utilization management programs
Employers classified as unmanaged experienced an annual average increase in specialty drug spending per member per year of 27.8 percent. However, employers classified as tightly managed saw an annual increase in specialty drug spending per member per year of 13.6 percent, half that of the unmanaged group and nearly one-third lower than the average annual projected specialty drug trend. In addition, tightly managed programs saw higher average member adherence rates in top therapy classes such as multiple sclerosis and oncology.